Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Koeller

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
DICP : the Annals of Pharmacotherapy|November 1, 1990
Rational use of antibiotics in the critically ill patientJ M Koeller
Pharmacotherapy|February 20, 1998
Clinical guidelines for the treatment of cancer-related anemiaJ M Koeller
American Journal of Hospital Pharmacy|August 1, 1990
Understanding cancer painJ M Koeller
American Journal of Hospital Pharmacy|November 1, 1989
Biologic response modifiers: the interferon alfa experienceJ M Koeller
Pharmacotherapy|November 1, 1994
Recombinant interleukin-2J K Bruton, J M Koeller
DICP : the Annals of Pharmacotherapy|May 1, 1991
Idarubicin: a second-generation anthracyclineS M Fields, J M Koeller
Cancer Treatment Reports|September 1, 1981
Phase I trial of PCNU administered by 5-day coursesR H Earhart, J M Koeller, H L Davis
Cancer Treatment Reports|May 1, 1981
Phase I trial of ICRF-187 by 48-hour continuous infusionJ M Koeller, R H Earhart, H L Davis
Pharmacoeconomics|October 28, 1999
Economic analysis of carboplatin versus cisplatin in lung and ovarian cancerZ M Khan, K L Rascati, J M Koeller
Cancer Treatment Reports|May 1, 1982
Phase I trial of 6-diazo-5-oxo-L-norleucine (DON) administered by 5-day coursesR H Earhart, J M Koeller, H L Davis
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
DICP : the Annals of Pharmacotherapy|November 1, 1990
Rational use of antibiotics in the critically ill patientJ M Koeller
Pharmacotherapy|February 20, 1998
Clinical guidelines for the treatment of cancer-related anemiaJ M Koeller
American Journal of Hospital Pharmacy|August 1, 1990
Understanding cancer painJ M Koeller
American Journal of Hospital Pharmacy|November 1, 1989
Biologic response modifiers: the interferon alfa experienceJ M Koeller
Pharmacotherapy|November 1, 1994
Recombinant interleukin-2J K Bruton, J M Koeller
DICP : the Annals of Pharmacotherapy|May 1, 1991
Idarubicin: a second-generation anthracyclineS M Fields, J M Koeller
Cancer Treatment Reports|September 1, 1981
Phase I trial of PCNU administered by 5-day coursesR H Earhart, J M Koeller, H L Davis
Cancer Treatment Reports|May 1, 1981
Phase I trial of ICRF-187 by 48-hour continuous infusionJ M Koeller, R H Earhart, H L Davis
Pharmacoeconomics|October 28, 1999
Economic analysis of carboplatin versus cisplatin in lung and ovarian cancerZ M Khan, K L Rascati, J M Koeller
Cancer Treatment Reports|May 1, 1982
Phase I trial of 6-diazo-5-oxo-L-norleucine (DON) administered by 5-day coursesR H Earhart, J M Koeller, H L Davis
Pageof 3